What dose of cefdinir suspension 250 mg/5 mL should be given to a 36‑pound (≈16 kg) child, and how often?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefdinir Dosing for a 36-Pound Child

For a 36-pound (16.3 kg) child, administer cefdinir 5 mL of the 250 mg/5 mL suspension twice daily (every 12 hours) or 10 mL once daily (every 24 hours), providing a total daily dose of 14 mg/kg. 1

Weight-Based Dosing Calculation

  • The FDA-approved pediatric dosing for cefdinir is 14 mg/kg per day, which can be administered as either 7 mg/kg every 12 hours or 14 mg/kg every 24 hours (maximum 600 mg/day). 1

  • For a child weighing 36 pounds (16.3 kg), the calculated daily dose is approximately 228 mg per day (16.3 kg × 14 mg/kg). 1

  • Using the 250 mg/5 mL suspension, this translates to:

    • Twice-daily regimen: 5 mL every 12 hours (250 mg/day total)
    • Once-daily regimen: 10 mL every 24 hours (500 mg/day total) 1

Dosing Frequency Considerations

  • Once-daily dosing (14 mg/kg every 24 hours) is as effective as twice-daily dosing (7 mg/kg every 12 hours) for most indications, including acute otitis media, sinusitis, and pharyngitis/tonsillitis, and may improve adherence. 1, 2

  • For uncomplicated skin and skin structure infections, cefdinir should be administered twice daily because once-daily dosing has not been studied in this indication. 1

Treatment Duration by Indication

  • Acute bacterial otitis media: 5–10 days (twice daily) or 10 days (once daily) 1
  • Acute maxillary sinusitis: 10 days (either regimen) 1
  • Pharyngitis/tonsillitis: 5–10 days (twice daily) or 10 days (once daily) 1
  • Uncomplicated skin infections: 10 days (twice daily only) 1

Clinical Context and Rationale

  • Cefdinir is an alternative oral cephalosporin recommended by the Infectious Diseases Society of America for β-lactamase-producing Haemophilus influenzae when amoxicillin or amoxicillin-clavulanate cannot be used. 3

  • The drug provides excellent coverage against common respiratory pathogens, including β-lactamase-producing H. influenzae and Moraxella catarrhalis, as well as penicillin-susceptible Streptococcus pneumoniae. 2, 4, 5

  • Cefdinir distributes well into respiratory tissues, middle ear fluid, and skin, supporting its use in community-acquired infections. 2, 5

Administration Guidelines

  • Cefdinir suspension may be administered without regard to meals. 1

  • After reconstitution, the suspension should be stored at room temperature (25°C/77°F) in a tightly closed container and shaken well before each dose. 1

  • The suspension may be used for 10 days after mixing, after which any unused portion must be discarded. 1

Common Pitfalls to Avoid

  • Do not use once-daily dosing for skin infections—the FDA label explicitly requires twice-daily administration for this indication because once-daily regimens have not been studied. 1

  • Do not exceed the maximum daily dose of 600 mg, regardless of weight-based calculations. 1

  • Diarrhea is the most common adverse effect (reported in 12.5% of pediatric patients in some studies); counsel families accordingly and ensure adequate hydration. 4, 6

  • Cefdinir is not first-line therapy for community-acquired pneumonia—amoxicillin at 90 mg/kg/day remains the preferred agent for fully immunized children, with cefdinir reserved as an alternative for β-lactam allergy or β-lactamase-producing organisms. 3, 7

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.